The action of 10 mg famotidine versus 200 mg cimetidine: onset and magnitude of antisecretory action within the first 2 hours after administration.

Am J Ther

Johnson & Johnson Merck Consumer Pharmaceuticals Co., Fort Washington, PA 19034, USA.

Published: March 1998

The introduction of over-the-counter histamine2 -receptor antagonists (H2 -RAs) makes it important to characterize these agents in terms of their different times to onset of action and magnitude of effect. The time to onset of action and the degree of gastric acid inhibition of the H2 -RAs famotidine and cimetidine at dosage levels approved for over-the-counter use (10 mg famotidine and 200 mg cimetidine) were compared. Twenty-four subjects with a history of heartburn of at least 2 months duration received 10 mg famotidine, 200 mg cimetidine, or placebo in a randomly assigned sequence of three treatment periods. Each period began with an overnight fast, followed by insertion of an intragastric pH probe during a 1-hour baseline monitoring phase, and, 1 hour later, administration of the test medications and monitoring of intragastric pH for an additional 2-hour period. The onset of acid inhibition occurred approximately 35 minutes after administration of either famotidine or cimetidine. Famotidine provided a significantly greater degree of efficacy on all three parameters monitored: percentage of time that gastric pH values were greater than 3.0, mean area-under-the-pH-curve-versus-time curve, and median pH (obtained at 5-minute intervals). Clearly, the over-the-counter dosage of famotidine (10 mg) provided gastric pH elevations that were as rapid and of superior degree than those induced by cimetidine 200 mg.

Download full-text PDF

Source
http://dx.doi.org/10.1097/00045391-199803000-00007DOI Listing

Publication Analysis

Top Keywords

200 cimetidine
12
onset action
8
acid inhibition
8
famotidine cimetidine
8
famotidine 200
8
famotidine provided
8
cimetidine
6
famotidine
6
action
4
action famotidine
4

Similar Publications

Calcific tendinitis of the rectus femoris is rare. This clinical report presents five cases of management of calcific tendinitis of the rectus femoris. Between July 2018 and March 2023, five patients visited our institution, where they were treated for calcific tendinitis of the rectus femoris.

View Article and Find Full Text PDF

Assessment of antinociceptive property of L. and possible mechanism of action in the formalin and writhing models of nociception in mice.

Korean J Pain

July 2024

Department of Basic Sciences and Pathobiology, Faculty of Veterinary Medicine, Razi University, Kermanshah, Iran.

Background: has bioactive constituents and has been used for therapeutic actions. The present study was undertaken to investigate the mechanisms underlying pain-relieving effects of the hydroethanolic extract of C. scolymus (HECS).

View Article and Find Full Text PDF

Introduction: Clozapine is an atypical antipsychotic used to treat refractory schizophrenia; in both therapeutic use and overdose, it can cause significant toxicity. We report two young siblings who developed altered mental status after ingesting clozapine due to a pharmacy dispensing error.

Case Report: A 5-year-old girl and her 19-month-old sister presented to the emergency department (ED) with altered mental status after they took their first dose of what was believed to be cimetidine, prescribed to treat molluscum contagiosum.

View Article and Find Full Text PDF

The Lee-Goldburg condition for homonuclear decoupling in H magic-angle spinning (MAS) solid-state NMR sets the angle , corresponding to arctan of the ratio of the rf nutation frequency, , to the rf offset, to be the magic angle, , equal to tan(√2) = 54.7°. At 60 kHz MAS, we report enhanced decoupling compared to MAS alone in a H spectrum of N-glycine with at = 30° for a of ∼100 kHz at a H Larmor frequency, , of 500 MHz and 1 GHz, corresponding to a high chemical shift scaling factor () of 0.

View Article and Find Full Text PDF

Drug discovery and development for stroke is challenging as evidenced by few drugs that have advanced beyond a Phase III clinical trial. Memantine is a N-methyl-d-aspartate (NMDA) receptor antagonist that has been shown to be neuroprotective in various preclinical studies. We have identified an endogenous BBB uptake transport system for memantine: organic cation transporters 1 and 2 (Oct1/Oct2).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!